Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ACCO Brands Corporation Declares Quarterly Dividend
-
Paysafe Announces Changes to its Board of Directors
-
Where Asia Meets the U.S.: Startup World Cup and East Meets West Unite in Hawaii
-
Silver Storm Invites PDAC 2026 Attendees to Visit the Company at Booth #2540 on March 1-4
-
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
-
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
-
Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium
-
Aurora Mobile Partners with China Post Securities to Deliver Millisecond Messaging and Enhance Digital Financial Services
-
Enwex Netherlands, France and Spain Wind Futures Now Live for Trading on Abaxx Exchange
-
Gogo Announces Fourth Quarter and Full Year 2025 Results
-
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
-
Notice of the Annual General Meeting of Orrön Energy AB
-
Intruder Recognized as a 2026 G2 Best UK Software Company
-
IBC Advanced Alloys Reports Financial Results for the Quarter Ended December 2025
-
Goldgroup Completes Sale of Pinos Project
-
Nextech3D.ai Launches Eventdex AI Voice Concierge, Powered by OpenClaw, Twilio, AWS EC2 & Pinecone - Expanding Its AI Events Operating System
-
Torq Provides Santa Cecilia Project Update
-
OTC Markets Group Welcomes RUA GOLD INC. to OTCQX
-
European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influen
-
Clough Global Equity Fund Section 19(a) Notice
-
Clough Global Dividend and Income Fund Section 19(a) Notice
-
Reaves Utility Income Fund Section 19(a) Notice
-
Off-highway Plastics Market worth $13.08 billion by 2030 - Exclusive Report by MarketsandMarkets™
-
Clough Global Opportunities Fund Section 19(a) Notice
-
Zoomcar Announces Launch of Offer to Exchange Outstanding Warrants for Common Stock
-
Happy Belly Food Group Announces Closing of the Sale of Holy Crap Foods as it Focuses on Accelerating its QSR Businesses
-
YieldMax® Introduces Portfolio Option Income Strategy ETF on Strategic Metals & Mining (MINY)
-
AECOM to provide design, environmental, and project management services for Sound Transit’s Seattle-area regional transit expansion
-
Natural Resource Partners L.P. Reports Fourth Quarter and Full Year 2025 Results and Announces Special Distribution
-
Critical One Energy Regains Full Control of Uranium and Copper Assets in Namibia, Africa
-
Commercial Office Cleaning vs. In-House Janitorial Staff: A Cost & Quality Comparison
-
Endeavour Silver Announces Q4 2025 Financial Results; Earnings Call at 10AM PST (1PM EST) Today
-
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance
-
GFL Environmental Inc. Announces Renewal of Share Repurchase Programs
-
SourceDay Named to The Hackett Group’s 2025–2026 50 to Know List
-
White Oil Market worth $2.77 billion by 2030 - Exclusive Report by MarketsandMarkets™
-
Global governance seminar held in Geneva, marking launch of English edition of Volume I of "China's Governance under Xi Jinping's Leadership"
-
Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors
-
Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer
-
Delek US Holdings Reports Fourth Quarter 2025 Results
-
The Rise of AI in Music Creation: Transforming How Songs Are Made
-
Delek Logistics Reports Record Fourth Quarter 2025 Results
-
TXNM Energy Reports 2025 Results, Transaction and Regulatory Updates
-
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
-
Xmarket Launches Beta on BNB Chain Mainnet:
-
Jura Provides Disclosure Regarding Shareholder Claim by PEL’s CEO
-
LALAL.AI Expands Its Developer API With AI Multi-Stem Separation & Voice Cloning
-
Banco Itaú Chile Announces Fourth Quarter 2025 Management Commentary
-
Target's Entire Cereal Assortment Will be Made Without Certified Synthetic Colors
